Tag: Sentinel Initiative

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

The FDA monitors generic drugs after approval using real-world data, adverse event reports, and AI tools to ensure ongoing safety. Despite bioequivalence testing, post-market surveillance catches rare side effects and manufacturing issues that clinical trials miss.